Arbutus Biopharma (ABUS) Receivables - Net (2010 - 2026)
Arbutus Biopharma (ABUS) posted Receivables - Net of $179.37 million for Q2 2026, compared with $1.03 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma's Receivables - Net came in at $1.45 million, down 39.9% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
- In prior years, Arbutus Biopharma's Receivables - Net was $2.41 million in FY2024 (+35.6%), $1.78 million in FY2023 (+31.4%), $1.35 million in FY2022 (+50.4%) and $899,000 in FY2021 (-31.5%).
- The Q2 2026 figure stands as the highest quarterly Receivables - Net in data going back to Q4 2010.
- On a year-over-year basis, Receivables - Net increased in 1 of the last six quarters, with an average decline of 26.8%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q1 2023, with growth of 102.9%; the weakest was Q1 2025, with a decline of 44.7%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $178.74 million (Q1 2026), $1.45 million (Q4 2025) and $905,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Arbutus Biopharma | 841.23 Mn | 468.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.37 Mn |
| Mar 31, 2026 | 178.74 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 2.66 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 1.67 Mn |
API Access
Arbutus Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();